Improving medication adherence in young cancer patients
A Pilot Feasibility Trial of a Tailored Intervention to Improve Adherence in Adolescents and Young Adults with Cancer
This study is looking to help teenagers and young adults with cancer stick to their medication by figuring out their unique challenges and providing personalized support to make it easier for them to follow their treatment plans.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10753573 on NIH RePORTER |
What this research studies
This research aims to enhance medication adherence among adolescents and young adults (AYAs) with cancer by tailoring interventions to address their specific barriers. The study recognizes that up to 60% of AYAs struggle to follow their treatment plans, which can lead to serious health risks. By identifying individual challenges and applying customized behavior change techniques, the research seeks to create a more effective approach to support these patients in sticking to their medication regimens. The pilot trial will assess the feasibility of this tailored intervention in a clinical setting.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults aged 15 to 39 who are undergoing treatment for cancer.
Not a fit: Patients who are not currently receiving cancer treatment or those outside the age range of 15 to 39 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment adherence and health outcomes for young cancer patients.
How similar studies have performed: Previous research has shown that tailored interventions can be more effective than standard approaches, indicating potential success for this novel strategy.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Mcgrady, Meghan Eileen — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Mcgrady, Meghan Eileen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.